Regulatory Development & Policy
Building the regulatory framework and policy architecture the Caribbean pharmaceutical sector needs.
How We’re Accomplishing This
BPI is establishing the legal, regulatory, and institutional foundations to accelerate pharmaceutical manufacturing, trade, and market access across Barbados and the wider region. The Barbados Medical Products Authority (BMPA) Act, passed by Parliament on 1 July 2026, creates an independent regulator for pharmaceuticals, vaccines, and medical devices. Led by Dr. Maryam Hinds under BPI, this work is part of the Government's broader legislative modernization agenda.
In parallel, BPI is advancing a regulatory reliance framework built on trusted regulatory authorities, including potential collaboration with Nigeria's NAFDAC. With PAHO support, Barbados has completed three WHO Global Benchmarking Tool self-assessments and developed an Institutional Development Plan to guide BMPA's alignment with international standards. Strategic partnerships with PAHO/WHO and leading regulatory and scientific institutions across the UK, Africa, Europe, and India are further strengthening regulatory capacity, workforce development, and scientific collaboration.
Together, these efforts are positioning Barbados as a regulatory leader across CARICOM, Africa, and Latin America, giving the region a trusted, internationally aligned pathway to bring pharmaceutical products to market.
Build With Us
Careers
Every role at BPI contributes to building the pharmaceutical infrastructure that the Caribbean depends on. Join a team working at the intersection of government, investment, manufacturing, and regional health policy.
The gateway is open. Ready to build with us?
Deliberately. Piece by piece. With the people it is for. If you are a partner, investor, or government, we would like to build with you.
